Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2017, Article ID 1824794, 9 pages
https://doi.org/10.1155/2017/1824794
Review Article

The Nonradiographic Axial Spondyloarthritis, the Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis: The Tangled Skein of Rheumatology

Department of Rheumatology, The Joint Disease Clinic, ISIC Superspeciality Hospital, Vasant Kunj, New Delhi 110070, India

Correspondence should be addressed to Anand N. Malaviya; moc.oohay@ayivalam_dnana

Received 30 January 2017; Revised 4 April 2017; Accepted 10 April 2017; Published 7 May 2017

Academic Editor: Ruben Burgos-Vargas

Copyright © 2017 Anand N. Malaviya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Taurog, A. Chhabra, and R. A. Colbert, “Ankylosing spondylitis and axial spondyloarthritis,” New England Journal of Medicine, vol. 374, no. 26, pp. 2563–2574, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. M. A. Khan, “Update on spondyloarthropathies,” Annals of Internal Medicine, vol. 136, no. 12, pp. 896–907, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. A. N. Malaviya, S. Sawhney, N. K. Mehra, and U. Kanga, “Seronegative arthritis in South Asia: an up-to-date review,” Current Rheumatology Reports, vol. 16, no. 16, pp. 413–426, 2014. View at Google Scholar
  4. J. M. Moll, I. Haslock, I. F. Macrae, and V. Wright, “Associations between ankylosing spondylitis, psoriatic arthritis, reiterʼs disease, the intestinal arthropathies, and behcetʼs syndrome,” Medicine (Baltimore), vol. 53, no. 5, pp. 343–364, 1974. View at Publisher · View at Google Scholar
  5. V. Wright, “Seronegative polyarthritis. a unified concept,” Arthritis and Rheumatism, vol. 21, no. 6, pp. 619–633, 1978. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Dougados, S. van der Linden, R. Juhlin et al., “The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy,” Arthritis and Rheumatism, vol. 34, no. 10, pp. 1218–1227, 1991. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Braun, D. Van der Heijde, M. Dougados et al., “Staging of patients with ankylosing spondylitis: a preliminary proposal,” Annals of the Rheumatic Diseases, vol. 61, no. 3, pp. iii19–iii23, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Van Tubergen and U. Weber, “Diagnosis and classification in spondyloarthritis: identifying a chameleon,” Nature Reviews Rheumatology, vol. 8, no. 5, pp. 253–261, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Rothschild and E. Feldtkeller, “Spondyloarthritis in antiquity and in history,” in Oxford Textbook of Axial Spondyloarthritis, R. Inman and J. Sieper, Eds., Chapter 1, pp. 1–12, Oxford University Press, Oxford, UK, 2016. View at Google Scholar
  10. S. van der Linden, H. A. Valkenburg, and A. Cats, “Evaluation of diagnostic criteria for ankylosing spondylitis. a proposal for modification of the New York criteria,” Arthritis and Rheumatism, vol. 27, no. 4, pp. 361–368, 1984. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Rudwaleit, D. van Der Heijde, R. Landewé et al., “The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection,” Annals of the Rheumatic Diseases, vol. 68, no. 6, pp. 777–783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. F. van Gaalen, D. van der Heijde, and M. Dougados, “Diagnosis and classification of axial spondyloarthritis,” in Oxford Textbook of Axial Spondyloarthritis, R. Inman and J. Sieper, Eds., pp. 19–28, Oxford University Press, Oxford, UK, 2016. View at Google Scholar
  13. A. Calin, J. Porta, J. F. Fries, and D. J. Schurman, “Clinical history as a screening test for ankylosing spondylitis,” The Journal of the American Medical Association, vol. 237, no. 24, pp. 2613–2614, 1977. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Prakash, N. K. Mehra, S. Bhargava, and A. N. Malaviya, “HLA B27 related "unclassifiable" seronegative spondyloarthropathies,” Annals of the Rheumatic Diseases, vol. 42, no. 6, pp. 640–643, 1983. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Amor, M. Dougados, and M. Mijiyawa, “Criteres de classification des spondyloarthropathies,” Revue du Rhumatisme et des Maladies Ostéo-Articulaires, vol. 57, no. 1, pp. 85–89, 1990. View at Google Scholar
  16. M. Rudwaleit, A. Metter, J. Listing, J. Sieper, and J. Braun, “Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria,” Arthritis and Rheumatism, vol. 54, no. 2, pp. 569–578, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Sieper, D. van der Heijde, R. Landewé et al., “New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS),” Annals of the Rheumatic Diseases, vol. 68, no. 6, pp. 784–788, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. D. D. Gladman, “Editorial: what is peripheral spondyloarthritis?” Arthritis and Rheumatology, vol. 67, no. 4, pp. 865–868, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Stolwijk, I. Essers, A. van Tubergen et al., “The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study,” Annals of the Rheumatic Diseases, vol. 74, no. 7, pp. 1373–1378, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Mau, H. Zeidler, R. Mau et al., “Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year follow-up,” Journal of Rheumatology, vol. 15, no. 7, pp. 1109–1114, 1988. View at Google Scholar · View at Scopus
  21. A. Kumar, M. Bansal, D. N. Srivastava et al., “Long-term outcome of undifferentiated spondylarthropathy,” Rheumatology International, vol. 20, no. 6, pp. 221–224, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Boonen, J. Sieper, D. van der Heijde et al., “The burden of non-radiographic axial spondyloarthritis,” Seminars in Arthritis and Rheumatism, vol. 44, no. 5, pp. 556–562, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Braun, M. Bollow, L. Neure et al., “Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis,” Arthritis and Rheumatism, vol. 38, no. 4, pp. 499–505, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Rudwaleit, J. Listing, E. Marker-Hermann, H. Zeidler, J. Braun, and J. Sieper, “The burden of disease in patients with ankylosing spondylitis (AS) and pre-radiographic axial spondyloarthritis,” Arthritis and Rheumatism, vol. 50, 9, no. 11, p. S211, 2004. View at Google Scholar
  25. http://www.webmd.com/rheumatoid-arthritis/news/19991110/fda-approves-remicade-for-treatment-of-rheumatoid-arthritis.
  26. H. Marzo-Ortega, D. McGonagle, P. O'Connor, and P. Emery, “Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study,” Arthritis and Rheumatism, vol. 44, no. 9, pp. 2112–2117, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Braun, J. Brandt, J. Listing et al., “Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial,” The Lancet, vol. 359, no. 9313, pp. 1187–1193, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. F. van Den Bosch, E. Kruithof, D. Baeten et al., “Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy,” Arthritis and Rheumatism, vol. 46, no. 3, pp. 755–765, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. J. D. Gorman, K. E. Sack, and J. C. Davis Jr., “Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α,” New England Journal of Medicine, vol. 346, no. 18, pp. 1349–1356, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. W. P. Maksymowych, G. S. Jhangri, R. G. Lambert et al., “Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety,” Journal of Rheumatology, vol. 29, no. 5, pp. 959–965, 2002. View at Google Scholar · View at Scopus
  31. M. Breban, E. Vignon, P. Claudepierre et al., “Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study,” Rheumatology, vol. 41, no. 11, pp. 1280–1285, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Brandt, A. Khariouzov, J. Listing et al., “Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis,” Arthritis and Rheumatism, vol. 48, no. 6, pp. 1667–1675, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. J. C. Davis Jr., D. van Der Heijde, J. Braun et al., “Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial,” Arthritis and Rheumatism, vol. 48, no. 11, pp. 3230–3236, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Braun, X. Baraliakos, W. Golder et al., “Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system,” Arthritis and Rheumatism, vol. 48, no. 4, pp. 1126–1136, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. J. C. M. Oostveen, R. L. Prevo, J. A. den Boer, and M. A. F. J. Van De Laar, “Early detection of sacroiliitis on magnetic resonance imaging and subsequent development of sacroiliitis on plain radiography. A prospective, longitudinal study,” Journal of Rheumatology, vol. 26, no. 9, pp. 1953–1958, 1999. View at Google Scholar · View at Scopus
  36. H. Ahlström, N. Feltelius, R. Nyman, and R. Hällgren, “Magnetic resonance imaging of sacroiliac joint inflammation,” Arthritis and Rheumatism, vol. 33, no. 12, pp. 1763–1769, 1990. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Braun, M. Bollow, U. Eggens, H. König, A. Distler, and J. Sieper, “Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients,” Arthritis and Rheumatism, vol. 37, no. 7, pp. 1039–1045, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Rudwaleit, A. G. Jurik, K. G. A. Hermann et al., “Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group,” Annals of the Rheumatic Diseases, vol. 68, no. 10, pp. 1520–1527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Sieper and M. Rudwaleit, “How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?” Annals of the Rheumatic Diseases, vol. 64, 4, no. 10, pp. iv61–iv64, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Arends, E. van Der Veer, C. G. M. Kallenberg, E. Brouwer, and A. Spoorenberg, “Baseline predictors of response to TNF-α blocking therapy in ankylosing spondylitis,” Current Opinion in Rheumatology, vol. 24, no. 3, pp. 290–298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. S. M. van Der Linden, H. A. Valkenburg, B. M. De Jongh, and A. Cats, “The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. a comparison of relatives of spondylitis patients with the general population,” Arthritis and Rheumatism, vol. 27, no. 3, pp. 241–249, 1984. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Said-Nahal, C. Miceli-Richard, J.-M. Berthelot et al., “The familial form of spondylarthropathy: a clinical study of 115 multiplex families,” Arthritis and Rheumatism, vol. 43, no. 6, pp. 1356–1365, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. F. D. Hart and K. C. Robinson, “Ankylosing spondylitis in women,” Annals of the Rheumatic Diseases, vol. 18, no. 1, pp. 15–23, 1959. View at Publisher · View at Google Scholar · View at Scopus
  44. E. Gracey, Y. Yao, B. Green et al., “Sexual dimorphism in the th17 signature of ankylosing spondylitis,” Arthritis and Rheumatology, vol. 68, no. 3, pp. 679–689, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. U. Kiltz, X. Baraliakos, P. Karakostas et al., “Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?” Arthritis Care and Research, vol. 64, no. 9, pp. 1415–1422, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Wallis, N. Haroon, R. Ayearst, A. Carty, and R. D. Inman, “Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?” Journal of Rheumatology, vol. 40, no. 12, pp. 2038–2041, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. A. N. Malaviya, A. Kalyani, and R. Rawat, “Is radiographic axial SpA a distinct subset with more severe axial involvement? Comment on the article by Deodhar et al.,” Arthritis and Rheumatology, vol. 67, article 856, no. 3, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. A. N. Malaviya, A. Kalyani, R. Rawat, and S. B. Gogia, “Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi,” International Journal of Rheumatic Diseases, vol. 18, no. 7, pp. 736–741, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Jeong, J. Y. Yoon, E.-J. Park et al., “Clinical characteristics of nonradiographic axial spondyloarthritis in Korea: a comparison with ankylosing spondylitis,” International Journal of Rheumatic Diseases, vol. 18, no. 6, pp. 661–668, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. X. Baraliakos and J. Braun, “Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences,” Rheumatic Musculoskeletal Diseases Open, vol. 1, 1, no. 12015, Article ID e000053, 2015. View at Google Scholar
  51. P. C. Robinson, B. P. Wordsworth, J. D. Reveille, and M. A. Brown, “Axial spondyloarthritis: a new disease entity, not necessarily early ankylosing spondylitis,” Annals of the Rheumatic Diseases, vol. 72, no. 2, pp. 162–164, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. F. W. L. Tsui, H. W. Tsui, A. Akram, N. Haroon, and R. D. Inman, “The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis,” Application of Clinical Genetics, vol. 7, no. 5, pp. 105–115, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Vendelbosch, S. C. Heslinga, M. John et al., “Study on the protective effect of the KIR3DL1 gene in ankylosing spondylitis,” Arthritis and Rheumatology, vol. 67, no. 11, pp. 2957–2965, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Ustun, F. Tok, U. Kalyoncu et al., “Sclerostin and Dkk-1 in patients with ankylosing spondylitis,” Acta Reumatologica Portuguesa, vol. 39, no. 2, pp. 146–151, 2014. View at Google Scholar · View at Scopus
  55. D. J. Pradeep, A. Keat, and K. Gaffney, “Predicting outcome in ankylosing spondylitis,” Rheumatology, vol. 47, no. 7, pp. 942–945, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. M. M. Ward, M. R. Hendrey, J. D. Malley et al., “Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis,” Arthritis Care and Research, vol. 61, no. 7, pp. 859–866, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Ramiro, R. Landewé, A. van Tubergen et al., “Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis,” Rheumatic Musculoskeletal Diseases Open, vol. 1, no. 1, Article ID e000153, 2015. View at Publisher · View at Google Scholar
  58. P. Mandl, V. Navarro-Compán, and L. Terslev et al., “EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice,” Annals of the Rheumatic Diseases, vol. 74, no. 7, pp. 1327–1339, 2015. View at Google Scholar
  59. J. Braun, X. Baraliakos, K. A. Hermann, S. Xu, and B. Hsu, “Serum C-reactive protein levels demonstrate predictive value for radiographic and magnetic resonance imaging outcomes in patients with active ankylosing spondylitis treated with Golimumab,” The Journal of Rheumatology, vol. 43, no. 9, pp. 1704–1712, 2016. View at Publisher · View at Google Scholar
  60. M. Rudwaleit, M. A. Khan, and J. Sieper, “Commentary: the challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria?” Arthritis and Rheumatism, vol. 52, no. 4, pp. 1000–1008, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Z. Aydin, W. P. Maksymowych, A. N. Bennett, D. McGonagle, P. Emery, and H. Marzo-Ortega, “Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years,” Annals of the Rheumatic Diseases, vol. 71, no. 1, pp. 56–60, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Deodhar, J. D. Reveille, F. Van Den Bosch et al., “The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the assessment of spondyloarthritis international society in response to the US food and drug administration's comments and concerns,” Arthritis and Rheumatology, vol. 66, no. 10, pp. 2649–2656, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Sieper, D. van der Heijde, M. Dougados et al., “Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1),” Annals of the Rheumatic Diseases, vol. 72, no. 6, pp. 815–822, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. R. Landewé, J. Braun, A. Deodhar et al., “Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study,” Annals of the Rheumatic Diseases, vol. 73, no. 1, pp. 39–47, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Yim, “Axial spondyloarthritis: regulatory considerations on its use as an indication for drug development,” in FDA Arthritis Advisory Committee Meeting, introductory remarks, July 2013, http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/arthritisadvisorycommittee/ucm366488.pdf.
  66. A. Deodhar, V. Strand, J. Kay, and J. Braun, “The term “non-radiographic axial spondyloarthritis” is much more important to classify than to diagnose patients with axial spondyloarthritis,” Annals of the Rheumatic Diseases, vol. 75, no. 5, pp. 791–794, 2016. View at Publisher · View at Google Scholar · View at Scopus